LSTM Home > LSTM Research > LSTM Online Archive

Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios

Downloads

Downloads per month over past year

Mukandvire, Zindoga, Nyabadza, Farai, Malunguza, Noble J, Cuadros, Diego F, Shiri, Tinevimbo ORCID: https://orcid.org/0000-0002-9092-3268 and Musuka, Godfrey N (2020) 'Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios'. PLoS ONE, Vol 15, Issue 7, e0236003.

[img]
Preview
Text
Mukandavire et al COVID ms.pdf - Accepted Version
Available under License Creative Commons Attribution.

Download (562kB) | Preview

Abstract

The emergence and fast global spread of COVID-19 has presented one of the greatest public health challenges in modern times with no proven cure or vaccine. Africa is still early in this epidemic, therefore the extent of disease severity is not yet clear. We used a mathematical model to fit to the observed cases of COVID-19 in South Africa to estimate the basic reproductive number and critical vaccination coverage to control the disease for different hypothetical vaccine efficacy scenarios. We also estimated the percentage reduction in effective contacts due to the social distancing measures implemented. Early model estimates show that COVID-19 outbreak in South Africa had a basic reproductive number of 2.95 (95% credible interval [CrI] 2.83-3.33). A vaccine with 70% efficacy had the capacity to contain COVID-19 outbreak but at very higher vaccination coverage 94.44% (95% Crl 92.44-99.92%) with a vaccine of 100% efficacy requiring 66.10% (95% Crl 64.72-69.95%) coverage. Social distancing measures put in place have so far reduced the number of social contacts by 80.31% (95% Crl 79.76-80.85%). These findings suggest that a highly efficacious vaccine would have been required to contain COVID-19 in South Africa. Therefore, the current social distancing measures to reduce contacts will remain key in controlling the infection in the absence of vaccines and other therapeutics.

Item Type: Article
Subjects: WA Public Health > WA 105 Epidemiology
WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases
WA Public Health > Preventive Medicine > WA 115 Immunization
WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 505 Viral respiratory tract infections
Faculty: Department: Clinical Sciences & International Health > International Public Health Department
Digital Object Identifer (DOI): https://doi.org/10.1371/journal.pone.0236003
Depositing User: Tina Bowers
Date Deposited: 10 Aug 2020 13:00
Last Modified: 10 Aug 2020 13:00
URI: https://archive.lstmed.ac.uk/id/eprint/15278

Statistics

View details

Actions (login required)

Edit Item Edit Item